Elucidating Berberine's Therapeutic and Photosensitizer Potential through Nanomedicine Tools
- PMID: 37765251
- PMCID: PMC10535601
- DOI: 10.3390/pharmaceutics15092282
Elucidating Berberine's Therapeutic and Photosensitizer Potential through Nanomedicine Tools
Abstract
Berberine, an isoquinoline alkaloid extracted from plants of the Berberidaceae family, has been gaining interest due to anti-inflammatory and antioxidant activities, as well as neuro and cardiovascular protective effects in animal models. Recently, photodynamic therapy demonstrated successful application in many fields of medicine. This innovative, non-invasive treatment modality requires a photosensitizer, light, and oxygen. In particular, the photosensitizer can selectively accumulate in diseased tissues without damaging healthy cells. Berberine's physicochemical properties allow its use as a photosensitising agent for photodynamic therapy, enabling reactive oxygen species production and thus potentiating treatment efficacy. However, berberine exhibits poor aqueous solubility, low oral bioavailability, poor cellular permeability, and poor gastrointestinal absorption that hamper its therapeutic and photodynamic efficacy. Nanotechnology has been used to minimize berberine's limitations with the design of drug delivery systems. Different nanoparticulate delivery systems for berberine have been used, as lipid-, inorganic- and polymeric-based nanoparticles. These berberine nanocarriers improve its therapeutic properties and photodynamic potential. More specifically, they extend its half-life, increase solubility, and allow a high permeation and targeted delivery. This review describes different nano strategies designed for berberine delivery as well as berberine's potential as a photosensitizer for photodynamic therapy. To benefit from berberine's overall potential, nanotechnology has been applied for berberine-mediated photodynamic therapy.
Keywords: berberine; delivery systems; pharmacokinetics; photodynamic therapy; polymeric nanoparticles.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Metal-based nanoplatforms for enhancing the biomedical applications of berberine: current progress and future directions.Nanomedicine (Lond). 2025 Apr;20(8):851-868. doi: 10.1080/17435889.2025.2480051. Epub 2025 Mar 20. Nanomedicine (Lond). 2025. PMID: 40110809 Free PMC article. Review.
-
The Quest to Enhance the Efficacy of Berberine for Type-2 Diabetes and Associated Diseases: Physicochemical Modification Approaches.Biomedicines. 2020 Apr 18;8(4):90. doi: 10.3390/biomedicines8040090. Biomedicines. 2020. PMID: 32325761 Free PMC article. Review.
-
Lung Epithelial Cell Membrane-Camouflaged ROS-Activatable Berberine Nanoparticles for Targeted Treatment in Acute Lung Injury.Int J Nanomedicine. 2025 May 15;20:6163-6183. doi: 10.2147/IJN.S514611. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40391301 Free PMC article.
-
Nano strategies for berberine delivery, a natural alkaloid of Berberis.Biomed Pharmacother. 2018 Aug;104:465-473. doi: 10.1016/j.biopha.2018.05.067. Epub 2018 May 25. Biomed Pharmacother. 2018. PMID: 29793179 Review.
-
Biodistribution and pharmacokinetic profile of berberine and its metabolites in hepatocytes.Phytomedicine. 2022 Sep;104:154288. doi: 10.1016/j.phymed.2022.154288. Epub 2022 Jun 19. Phytomedicine. 2022. PMID: 35785560
Cited by
-
Formulation and characterization of BBR loaded niosomes using saponin as a nonionic biosurfactant investigating synergistic effects to enhance antibacterial activity.Sci Rep. 2025 Feb 12;15(1):5231. doi: 10.1038/s41598-025-87950-4. Sci Rep. 2025. PMID: 39939626 Free PMC article.
-
Berberine Targets PKM2 to Activate the t-PA-Induced Fibrinolytic System and Improves Thrombosis.Pharmaceuticals (Basel). 2024 Sep 17;17(9):1219. doi: 10.3390/ph17091219. Pharmaceuticals (Basel). 2024. PMID: 39338381 Free PMC article.
-
Improving the Antimicrobial Potency of Berberine for Endodontic Canal Irrigation Using Polymeric Nanoparticles.Pharmaceutics. 2024 Jun 9;16(6):786. doi: 10.3390/pharmaceutics16060786. Pharmaceutics. 2024. PMID: 38931907 Free PMC article.
-
Metal-based nanoplatforms for enhancing the biomedical applications of berberine: current progress and future directions.Nanomedicine (Lond). 2025 Apr;20(8):851-868. doi: 10.1080/17435889.2025.2480051. Epub 2025 Mar 20. Nanomedicine (Lond). 2025. PMID: 40110809 Free PMC article. Review.
-
Self-Microemulsifying Drug Delivery System to Enhance Oral Bioavailability of Berberine Hydrochloride in Rats.Pharmaceutics. 2024 Aug 24;16(9):1116. doi: 10.3390/pharmaceutics16091116. Pharmaceutics. 2024. PMID: 39339154 Free PMC article.
References
-
- Tran Q.L., Tezuka Y., Ueda J., Nguyen N.T., Maruyama Y., Begum K., Kim H.-S., Wataya Y., Tran Q.K., Kadota S. In vitro antiplasmodial activity of antimalarial medicinal plants used in Vietnamese traditional medicine. J. Ethnopharmacol. 2003;86:249–252. doi: 10.1016/S0378-8741(03)00045-X. - DOI - PubMed
-
- Ik V.M., Mdleková’ L., KoMdlová D. Lipoxygenase Inhibition and Antioxidant Properties of Protoberberine and Aporphine Alkaloids Isolated from Mahonia aquifolium. Planta Med. 1995;61:372–373. - PubMed
-
- Huang X., Wang P., Li T., Tian X., Guo W., Xu B., Huang G., Cai D., Zhou F., Zhang H., et al. Self-Assemblies Based on Traditional Medicine Berberine and Cinnamic Acid for Adhesion-Induced Inhibition Multidrug-Resistant Staphylococcus aureus. ACS Appl. Mater. Interfaces. 2020;12:227–237. doi: 10.1021/acsami.9b17722. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources